Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1) - Concepedia

Concepedia

Publication | Open Access

Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1)

DOI Full Paper Access

10

Citations

32

References

2022

Year

Tommaso Nicoletti, Salvatore Rossi, Maria Gabriella Vita, Alessia Perna, Gisella Guerrera, Federica Lino, Chiara Iacovelli, Daniele Di Natale, Anna Modoni, Luca Battistini,

Journal of Neurology

Abstract

Our findings support serum NfL as a potential biomarker of CNS damage in DM1, which deserves further evaluation on larger cross-sectional and longitudinal studies to test its ability in assessing brain disease severity and/or progression.

References

	Year	Citations

Page 1